Valuation (62%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 7.90 | N/A |
| PEG Ratio (TTM) | 0.39 | N/A |
| P/S Ratio (TTM) | 2.07 | N/A |
| P/B Ratio (TTM) | 1.68 | N/A |
| P/FCF Ratio (TTM) | N/A | N/A |
| Price to 5YR AVG Earnings Ratio | 15.96 | N/A |
| Price to 5YR AVG FCF Ratio | 33.25 | N/A |
Profitability (70%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 8.18% | N/A |
| ROE (TTM) | 23.65% | N/A |
| Net Profit Margin (TTM) | 26.50% | N/A |
| ROIC 5YR AVG | 25.41% | N/A |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 51.58% | 174.23% | 133.29% |
| Revenue | 9.86% | 19.75% | 17.92% |
| Net Income | 52.32% | 26.56% | 40.55% |
| Cash Flow | N/A | -119.78% | -38.95% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.78 | N/A |
| Quick Ratio (TTM) | 0.78 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | N/A | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 1.52 | N/A |
| LTL to 5YR AVG FCF | 0.04 | N/A |
| Shares Outstanding Growth 5YR AVG | 8.95% | N/A |